Press Releases | Medtronic

Month Year

Email alerts

May 21, 2013

Medtronic Announces CE Mark and Launch for CapSureFix Novus(TM) 5076 MRI Lead

Proven Lead Expands Access to MRI for Patients with Slow Heartbeat

TOLOCHENAZ - May 21, 2013 -- Medtronic today announced CE Mark (Conformité Européenne) and launch of its CapSureFix Novus(TM)5076 Lead, which is now approved in the EU for use in an MRI...
May 21, 2013

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

Three Analyses Presented at EuroPCR Demonstrate Device's Durability in Addressing Common Clinical Challenge

PARIS -- May 22, 2013 -- Addressing one of the most common clinical challenges in the treatment of complex coronary artery disease, three separate analyses on the program for EuroPCR this week...
May 20, 2013

Medtronic Receives 'CE' Mark for 'Export Advance' Aspiration Catheter

Backed by Robust Clinical Data on Broad Product Family, New Thrombus Removal System Offers Superior Deliverability

MINNEAPOLIS -- May 20, 2013 -- Expanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) announced today that the Export...
May 20, 2013

Medtronic to Honor Those Who Give Back After Receiving Life-Enhancing Medical Technology

Live On. Give On: Ten inspirational people will be awarded a $20,000 charitable donation and be honored at an awards celebration in Hawaii as part of the first annual Bakken Invitation

MINNEAPOLIS - May 20, 2013- Medtronic, Inc. (NYSE: MDT) announced today that applications are being accepted for the inaugural Bakken Invitation, a global program designed to celebrate those who,...
May 14, 2013

Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year 2013

MINNEAPOLIS - May 14, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year 2013 on Tuesday, May 21, 2013. A news release will...
May 11, 2013

Biventricular Pacing Reduces Symptoms and Improves Quality-of-Life in AV Block Patients with Heart Failure and Reduced Pumping Function

New Medtronic Data Show Additional Clinical Advantages in Pacing Both Ventricles Versus Conventional Right-Ventricular Pacing

MINNEAPOLIS and DENVER - May 11, 2013 - Medtronic, Inc. (NYSE: MDT) today announced new data demonstrating that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing...
May 10, 2013

New Research Demonstrates Success of Shock Avoidance in Medtronic Defibrillators

"Shock-Less" Late Breaking Clinical Trial: Providing Clinicians with ICD Programming Reports Improves Adherence to Evidence-Based Guidelines, Reduces All-Cause Shocks

MINNEAPOLIS and DENVER - May 10, 2013 -Validating its leadership in shock reduction research and technology, Medtronic, Inc. (NYSE: MDT) today announced the results of three clinical trials,...
May 10, 2013

Data Show Medtronic-Exclusive LIA Software Detects Non-Medtronic Lead Issues at a Greater Rate Than Standard Impedance Monitoring

MINNEAPOLIS and DENVER - May 10, 2013 - Data presented today at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions, show that Medtronic, Inc. (NYSE:MDT) Lead Integrity...
May 6, 2013

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

Newly designed Devices Result in Fewer Hospitalizations for Patients, Deliver Increased Longevity, and Improved Comfort

MINNEAPOLIS - May 6, 2013 - Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of its newest cardiac devices: the Viva®portfolio of...
May 5, 2013

Medtronic Partners with National Institute of Hospital Administration in China to Develop Diabetes Care Pathway

MINNEAPOLIS - May 1, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it has entered into an innovative partnership with the National Institute of Hospital Administration, an important think...
May 2, 2013

Medtronic Announces FDA Classification of Deep Brain Stimulation Lead Cap Communication

MINNEAPOLIS - May 2, 2013 - In keeping with its commitment to keep physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) issued an Urgent Medical Device Correction...
May 1, 2013

Ten Local High School Graduates Named 2013 Medtronic Scholars

Medtronic has committed more than $1.6 million in local scholarships to 100 students.

MINNEAPOLIS - May 1, 2013 - Medtronic today announced that 10 students have been selected as 2013 Medtronic Scholars. Each will receive a four-year scholarship totaling $16,000, as well as support...
Apr 29, 2013

Medtronic Expands Top Cervical-Upper Thoracic System

MEMPHIS, TENN. - April 29, 2013- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology announced today the U.S. launch of several new product line additions to the VERTEX SELECT®...
Apr 29, 2013

Medtronic Reports Initial Implants of Novel Stent Graft for Aortic Aneurysms Involving Branch Vessel

FDA's Early Feasibility Pilot Program for New Medical Devices Encourages Clinical Studies of Innovative Technology to Occur First in U.S.

MINNEAPOLIS -- April 29, 2013 -- Vascular specialists at Carolinas HealthCare System in Charlotte, N.C., and the Cleveland Clinic in Ohio recently performed the initial implants of a novel stent...
Apr 29, 2013

Medtronic Introduces New MAST ALIGNED(SM) Procedure for Minimally Invasive Multi-Level Spinal Fusions

MEMPHIS, TENN. - April 29, 2013- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology announced today the global launch of the MAST ALIGNEDSM procedure. This comprehensive surgical...
Apr 24, 2013

Medtronic Elects Scott C. Donnelly to the Board of Directors

MINNEAPOLIS - April 24, 2013 - Medtronic, Inc. (NYSE: MDT) today announced that its Board of Directors unanimously elected Scott C. Donnelly, chairman and CEO of Textron, Inc., a multi-industry...
Apr 24, 2013

The New England Journal of Medicine: Medtronic Biventricular Pacing Delivers Better Patient Outcomes for Those with AV Block and Reduced Pumping Function

MINNEAPOLIS - April 24, 2013 - Biventricular (BiV) pacing with Medtronic, Inc. (NYSE: MDT) cardiac resynchronization therapy (CRT) devices may offer a significant clinical advantage and improved...
Apr 15, 2013

American College of Cardiology Journal Publishes Outcomes of Diabetes Patients Treated with Medtronic's Resolute Stent

Implanted Medical Device for Coronary Artery Disease Performed As Well In Study Subjects With Diabetes Who Were Not Taking Insulin As In Those Without Diabetes

MINNEAPOLIS -- April 15, 2013 -- The current issue of JACC: Cardiovascular Interventions, a peer-reviewed journal published by the American College of Cardiology, includes an article that...
Apr 11, 2013

Medtronic Initiates U.S. Trial to Evaluate the Use of Subcutaneous Peripheral Nerve Stimulation for Chronic Back Pain

MINNEAPOLIS - April 11, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the first patient enrollments in the SubQStim II pivotal clinical trial to pursue U.S. Food and Drug Administration (FDA)...
Apr 9, 2013

Medtronic's Endurant 'AAA' Stent Graft Shows Sustained Durability in Complex Patients

Analysis of ENGAGE Registry Found Similarly Strong Outcomes with Device for Endovascular Treatment of Abdominal Aortic Aneurysms in Short and Standard Neck Lengths

MINNEAPOLIS -- April 9, 2013 -- Presented to endovascular specialists at the 35th Charing Cross International Symposium in London, a new analysis of clinical data on the Endurant AAA Stent Graft...
Apr 9, 2013

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

System Available in U.S. and Canada

MINNEAPOLIS - April 9, 2013 - Medtronic, Inc. (NYSE:MDT) today announced market release of the CardioGuide(TM) Implant System, a novel real-time navigation system for cardiac resynchronization...
Apr 4, 2013

Medtronic Receives 'CE' Mark for Sentrant Introducer Sheath, Complementing Market-Leading Aortic Stent Grafts

Distinguishing Features of New Accessory for Endovascular Interventions Include Optimal Seal for Superior Hemostasis and Reinforced Coil for Proven Kink Resistance

MINNEAPOLIS -- April 4, 2013 -- Complementing its market-leading portfolio of stent grafts for the endovascular repair of aortic aneurysms and related conditions, Medtronic, Inc. (NYSE: MDT)...
Apr 2, 2013

Medtronic Announces FDA Clearance and First Uses of New Oxygenation System for Adult Cardiac Surgery

New System Designed for Patient Safety, Ease of Use During Open-Heart Procedures

MINNEAPOLIS - April 2, 2013 - Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the first U.S. clinical uses of its new Affinity Fusion®...
Mar 19, 2013

Medtronic Announces Public Offering of Senior Notes

MINNEAPOLIS -- March 19, 2013 -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.0 billion of its 1.375% Senior Notes due 2018, $1.25 billion of its 2.750% Senior Notes due...
Mar 11, 2013

With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis

ACC.13 Presentation Features Unprecedented Data on Nearly 5,000 Patients, Including "All Comers," from Global RESOLUTE Clinical Program

SAN FRANCISCO -- March 11, 2013 -- Cardiologists at ACC.13 learned today that patients with coronary artery disease who received a Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) as...

Show per page